| Cost-effectiveness of cervical-cancer screening in five developing countries SJ Goldie, L Gaffikin, JD Goldhaber-Fiebert, A Gordillo-Tobar, C Levin, ... New England Journal of Medicine 353 (20), 2158-2168, 2005 | 909 | 2005 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 349 | 2019 |
| Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica JD Goldhaber-Fiebert, SN Goldhaber-Fiebert, ML Tristán, DM Nathan Diabetes Care 26 (1), 24, 2003 | 271 | 2003 |
| Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination JD Goldhaber-Fiebert, NK Stout, JA Salomon, KM Kuntz, SJ Goldie Journal of the National Cancer Institute 100 (5), 308-320, 2008 | 262 | 2008 |
| New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis S Liu, LE Cipriano, M Holodniy, DK Owens, JD Goldhaber-Fiebert Annals of internal medicine 156 (4), 279-290, 2012 | 252 | 2012 |
| The know-do gap in quality of health care for childhood diarrhea and pneumonia in rural India M Mohanan, M Vera-Hernández, V Das, S Giardili, JD Goldhaber-Fiebert, ... JAMA pediatrics 169 (4), 349-357, 2015 | 225 | 2015 |
| Cost-effectiveness of HPV 16, 18 vaccination in Brazil SJ Goldie, JJ Kim, K Kobus, JD Goldhaber-Fiebert, J Salomon, ... Vaccine 25 (33), 6257-6270, 2007 | 223 | 2007 |
| Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants JD Goldhaber-Fiebert, CY Jeon, T Cohen, MB Murray International journal of epidemiology 40 (2), 417-428, 2011 | 222 | 2011 |
| Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 196 | 2016 |
| Cost effectiveness of chimeric antigen receptor T-cell therapy in multiply relapsed or refractory adult large B-cell lymphoma JK Lin, LS Muffly, MA Spinner, JI Barnes, DK Owens, ... Journal of Clinical Oncology, 2105-2119, 2019 | 194 | 2019 |
| Design and analysis in dissemination and implementation research J Landsverk, CH Brown, P Chamberlain, L Palinkas, M Ogihara, S Czaja, ... Dissemination and implementation research in health: Translating science to …, 2012 | 176 | 2012 |
| Cost-effectiveness of helicopter versus ground emergency medical services for trauma scene transport in the United States MK Delgado, KL Staudenmayer, NE Wang, DA Spain, S Weir, DK Owens, ... Annals of emergency medicine 62 (4), 351-364. e19, 2013 | 152 | 2013 |
| Cost effectiveness of chimeric antigen receptor T-cell therapy in relapsed or refractory pediatric B-cell acute lymphoblastic leukemia JK Lin, BJ Lerman, JI Barnes, BC Boursiquot, YJ Tan, AQL Robinson, ... Journal of clinical oncology 36 (32), 3192-3202, 2018 | 141 | 2018 |
| Diabetes, its treatment, and catastrophic medical spending in 35 developing countries CM Smith-Spangler, J Bhattacharya, JD Goldhaber-Fiebert Diabetes care 35 (2), 319-326, 2012 | 139 | 2012 |
| Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure J Baras Shreibati, JD Goldhaber-Fiebert, D Banerjee, DK Owens, ... JACC: Heart Failure 5 (2), 110-119, 2017 | 133 | 2017 |
| Effect of integrated behavioral weight loss treatment and problem-solving therapy on body mass index and depressive symptoms among patients with obesity and depression: the … J Ma, LG Rosas, N Lv, L Xiao, MB Snowden, EM Venditti, MA Lewis, ... Jama 321 (9), 869-879, 2019 | 131 | 2019 |
| Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California: Study examines racial/ethnic disparities in COVID-19 risk, testing … MB Reitsma, AL Claypool, J Vargo, PB Shete, R McCorvie, WH Wheeler, ... Health Affairs 40 (6), 870-878, 2021 | 130 | 2021 |
| Cost-effectiveness of pertuzumab in human epidermal growth factor receptor 2–positive metastatic breast cancer BY Durkee, Y Qian, EL Pollom, MT King, SA Dudley, JL Shaffer, ... Journal of clinical oncology 34 (9), 902, 2016 | 128 | 2016 |
| Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997 BK Chen, B Seligman, JW Farquhar, JD Goldhaber-Fiebert Globalization and health 7, 1-10, 2011 | 126 | 2011 |
| Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling SJ Goldie, JD Goldhaber-Fiebert, GP Garnett Vaccine 24, S155-S163, 2006 | 123 | 2006 |
Joshua A. SalomonStanford University在 stanford.edu 的电子邮件经过验证
